Skip to main content
Have a personal or library account? Click to login
Relapsing Pericarditis: Prediction of Relapses, Risk Scores, and Role of Exercise Restriction Cover

Relapsing Pericarditis: Prediction of Relapses, Risk Scores, and Role of Exercise Restriction

Open Access
|Mar 2026

References

  1. Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025 Oct 22;46(40):3952-4041. doi: 10.1093/eurheartj/ehaf192
  2. Luis SA, LeWinter MM, Magestro M, et al. Estimating the US pericarditis prevalence using national health encounter surveillance databases. Curr Med Res Opin. 2022 Aug;38(8):1385-1389. doi: 10.1080/03007995.2022.2070381
  3. Klein AL, Wang TKM, Cremer PC, et al. Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging. JACC Cardiovasc Imaging. 2024 Aug;17(8):937-988. doi: 10.1016/j.jcmg.2024.04.010
  4. Wang TKM, Klein AL, Cremer PC, et al. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2025 Dec 23;86(25):2691-2719. doi: 10.1016/j.jacc.2025.05.023
  5. Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA. 2015 Oct 13;314(14):1498-1506. doi: 10.1001/jama.2015.12763
  6. Klein A, Cremer P, Kontzias A, et al. US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis. J Am Heart Assoc. 2021 Aug 3;10(15):e018950. doi: 10.1161/JAHA.120.018950
  7. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Relapsing pericarditis. Heart Br Card Soc. 2004;90(11):1364-1368. doi: 10.1136/hrt.2003.02612
  8. Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025 Oct 22;46(40):3952-4041. doi: 10.1093/eurheartj/ehaf192
  9. Imazio M, Belli R, Brucato A, et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. The Lancet. 2014 Jun 28;383(9936):2232-2237. doi: 10.1016/S0140-6736(13)62709-9
  10. Imazio M, Bobbio M, Cecchi E, et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005 Sep 26;165(17):1987-1991. doi: 10.1001/archinte.165.17.1987
  11. Imazio M, Brucato A, Cemin R, et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011 Aug 28;155(7):409-414. doi: 10.7326/0003-4819-155-7-201110040-00359
  12. Brucato A, Imazio M, Gattorno M, et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA. 2016 Nov 8;316(18):1906-1912. doi: 10.1001/jama.2016.15826
  13. Klein AL, Imazio M, Cremer P, et al. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med. 2021;384(1):31-41. doi: 10.1056/NEJMoa2027892
  14. Myachikova VY, Maslyanskiy AL, Moiseeva OM, et al. Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results. J Am Coll Cardiol. 2023 Jul 4;82(1):30-40. doi: 10.1016/j.jacc.2023.04.046
  15. Koprivanac M, Bauza K, Smedira N, et al. Radical Pericardiectomy and Use of Cardiopulmonary Bypass for Constrictive Pericarditis. Ann Thorac Surg. 2025 Dec 22;S0003-4975(25)01259-7. doi: 10.1016/j.athoracsur.2025.11.041
  16. Bryde RE, Cooper LT, Fairweather D, et al. Exercise After Acute Myocarditis When and How to Return to Sports. Cardiol Clin. 2023 Feb;41(1):107-115. doi: 10.1016/j.ccl.2022.08.009
  17. Claessen G, La Gerche A, De Bosscher R. Return to play after myocarditis: time to abandon the one-size-fits-all approach? Br J Sports Med. 2023 Oct;57(20):1282-1283. doi: 10.1136/bjsports-2022-106447
  18. Maestroni S, Di Corato PR, Cumetti D, et al. Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev. 2012 Nov12(1):60-65. doi: 10.1016/j.autrev.2012.07.023
  19. Imazio M, Brucato A, Barbieri A, et al. Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results From a Multicenter, Prospective Cohort Study. Circulation. 2013 Jul;42-49. doi: 10.1161/CIRCULATIONAHA.113.001531
  20. Imazio M, Battaglia A, Gaido L, et al. Recurrent pericarditis. Rev Med Interne. 2017 May;38(5):307-311. doi: 10.1016/j.revmed.2016.12.006
  21. Weiss T, Itelman E, Lotan D, et al. Pericarditis recurrence is associated with milder electrocardiographic, echocardiographic, and laboratory findings. Intern Emerg Med. 2024 Jun;19(4):1035-1039. doi: 10.1007/s11739-024-03579-7
  22. El Hajjar AH, Zalaquett Z, Rosenzveig A, et al. Investigating Pericarditis Diagnosis in a Tertiary Pericardial Center: A Descriptive Study. JACC Adv. 2025 Dec;4(12 Pt 2):102335. doi: 10.1016/j.jacadv.2025.102335
  23. Wassif H, Ghandakly E, Layoun H, et al. Autoimmune Pericarditis: Diagnosis and New Therapeutics. Curr Cardiol Rep. 2025 Jul 15;27(1):114. doi: 10.1007/s11886-025-02248-1
  24. Gaitonde S, Samols D, Kushner I. C-reactive protein and systemic lupus erythematosus. Arthritis Rheum. 2008 Dec 15;59(12):1814-1820. doi: 10.1002/art.24316
  25. Imazio M, Hoit BD. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013 Sep 30;168(2):648-652. doi: 10.1016/j.ijcard.2012.09.052
  26. Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011 Mar 15;123(10):1092-1097. doi: 10.1161/CIRCULATIONAHA.110.986372
  27. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318
  28. Yesilyaprak A, Kumar AK, Agrawal A, et al. Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis. J Am Coll Cardiol. 2024 Sep 24;84(13):1193-1204. doi: 10.1016/j.jacc.2024.05.072
  29. Yılmaz F, Yılmaz FK, Karagöz A, et al. Usefulness of neutrophil-to-lymphocyte ratio for predicting acute pericarditis outcomes. Acta Cardiol. 2022 Jul;77(5):422-430. doi: 10.1080/00015385.2021.1951998
  30. Eyiol H, Eyiol A, Sahin AT. Association of the Pan-Immune-Inflammatory Value (PIV) and HALP score with disease prognosis and recovery in patients with acute pericarditis: An observational cohort study. Medicine (Baltimore). 2025 Sep 12;104(37):e44460. doi: 10.1097/MD.0000000000044460
  31. Imazio M, Brucato A, Barbieri A, et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013 Jul 2;128(1):42-49. doi: 10.1161/CIRCULATIONAHA.113.001531
  32. Cremer PC, Lin D, Luis SA, et al. Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis. Eur Heart J Imaging Methods Pract. 2023 May 26;1(1):qyad003. doi: 10.1093/ehjimp/qyad003
  33. Parakh N, Mehrotra S, Seth S, et al. NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. Indian Heart J. 2015 Jan-Feb;67(1):40-44. doi: 10.1016/j.ihj.2015.02.008
  34. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013 Sep;26(9):965-1012.e15. doi: 10.1016/j.echo.2013.06.023
  35. Robbins MA, Pizzarello RA, Stechel RP, et al. Resting and exercise hemodynamics in constrictive pericarditis and a case of cardiac amyloidosis mimicking constriction. Cathet Cardiovasc Diagn. 1983;9(5):463-471. doi: 10.1002/ccd.1810090505
  36. Wang TKM, Ayoub C, Chetrit M, et al. Cardiac Magnetic Resonance Imaging Techniques and Applications for Pericardial Diseases. Circ Cardiovasc Imaging. 2022 Jul;15(7):e014283. doi: 10.1161/CIRCIMAGING.122.014283
  37. Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011 Oct 25;124(17):1830-1837. doi: 10.1161/CIRCULATIONAHA.111.026070
  38. Lazarou E, Lazaros G, Antonopoulos AS, et al. A risk score for pericarditis recurrence. Eur J Clin Invest. 2021 Nov;51(11):e13602. doi: 10.1111/eci.13602
  39. Kumar A, Sato K, Verma BR, et al. Quantitative assessment of pericardial delayed hyperenhancement helps identify patients with ongoing recurrences of pericarditis. Open Heart. 2018 Dec 16;5(2):e000944. doi: 10.1136/openhrt-2018-000944
  40. Imazio M, Andreis A, Klein A, et al. Scores for Risk Stratification of Pericarditis. Curr Cardiol Rep. 2025 Jun 24;27(1):101. doi: 10.1007/s11886-025-02259-y
  41. Imazio M, Andreis A, Lubian M, et al. The Torino Pericarditis Score: a new-risk stratification tool to predict complicated pericarditis. Intern Emerg Med. 2021 Oct;16(7):1921-1926. doi: 10.1007/s11739-021-02803-y
  42. Andreis A, Solano A, Balducci M, et al. INFLA-score: A new diagnostic paradigm to identify pericarditis. Hellenic J Cardiol. 2025 Jul-Aug;84:43-50. doi: 10.1016/j.hjc.2024.03.010
  43. Kytö V, Sipilä J, Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014 Oct 28;130(18):1601-1606. doi: 10.1161/CIRCULATIONAHA.114.010376
  44. Imazio M, Brucato A, Cemin R, et al. A Randomized Trial of Colchicine for Acute Pericarditis. N Engl J Med. 2013 Oct 17;369(16):1522-1528. doi: 10.1056/NEJMoa1208536
  45. Saraswati U, Bhalla JS, Tereshchenko LG, et al. Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis. Heart. 2025 Oct 20:;heartjnl-2024-325515. doi: 10.1136/heartjnl-2024-325515
  46. Grant JK, Shah NP. The Impact of Physical Activity on Pericarditis. Curr Cardiol Rep. 2021 Aug 27;23(10):150. doi: 10.1007/s11886-021-01578-0
  47. Meier C, Eisenblätter M, Gielen S, et al. Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)—An Important Risk Marker for Cardiac Disease. J Cardiovasc Dev Dis. 2024 Jan 26;11(2). doi: 10.3390/jcdd11020040
  48. Sharma P, Danieletto M, Whang JK, et al. Wearable Devices Detect Physiological Changes that Precede and Are Associated with Symptomatic and Inflammatory Rheumatoid Arthritis Flares. medRxiv [Preprint]. 2025 Sep 27;2025.09.24.25336585. doi: 10.1101/2025.09.24.25336585
  49. Imazio M, Cecchi E, Demichelis B, et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007 May 29;115(21):2739-2744. doi: 10.1161/CIRCULATIONAHA.106.662114
  50. Kim JH, Baggish AL, Levine BD, et al. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2025 Mar 18;85(10):1059-1108. doi: 10.1016/j.jacc.2024.12.025
  51. ACC [Internet]. Washington, DC: American College of Cardiology; c2026. Sivalokanathan S, Chokshi N. Pericarditis in Athletes: Approach to Exercise Restriction; 2022 Sep 7 [cited 2026 Feb 16]. Available from: https://www.acc.org/Latest-in-Cardiology/Articles/2022/09/06/11/53/Pericarditis-in-Athletes
  52. Pelliccia A, Sharma S, Gati S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease: The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC). Eur Heart J. 2021 Jan 1;42(1):17-96. doi: 10.1093/eurheartj/ehaa605
  53. Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010 Jun 3;411(0):785-793. doi: 10.1016/j.cca.2010.02.069
  54. Maron BJ, Zipes DP, Kovacs RJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 1;66(21):2343-2349. doi: 10.1016/j.jacc.2015.09.032
DOI: https://doi.org/10.14797/mdcvj.1777 | Journal eISSN: 1947-6108
Language: English
Page range: 14 - 26
Submitted on: Dec 29, 2025
Accepted on: Feb 6, 2026
Published on: Mar 10, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2026 Joseph El Roumi, Jibran Ikram, Tom Kai Ming Wang, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.